Pros and cons for C4d as a biomarker

Area of Science:

• Immunology
• Transplantation Medicine
• Biomarker Discovery

Background:

• The deposition of complement C4d has become a crucial indicator of antibody-mediated rejection in solid organ transplantation since the late 1990s.
• C4d visualizes the link between anti-donor antibodies and graft injury, reflecting classical complement activation.
• Limitations exist, such as C4d presence in ABO-incompatible transplants, which may indicate graft accommodation rather than rejection.

Purpose of the Study:

• To review the historical development, current applications, and future potential of C4d as a biomarker.
• To focus on C4d's established role in solid organ transplantation.
• To explore emerging roles of C4d in systemic autoimmune diseases and pregnancy.

Main Methods:

• Literature review of studies on C4d in transplantation, autoimmunity, and pregnancy.
• Analysis of C4d's diagnostic and prognostic value in various clinical contexts.
• Discussion of C4d's utility in conjunction with new complement-targeting therapies.

Main Results:

• C4d is a well-established marker for antibody-mediated rejection in organ grafts.
• C4d shows promise in identifying patients at risk for antibody-mediated damage in autoimmune conditions and during pregnancy.
• C4d may help select patients who could benefit from complement inhibition therapies.

Conclusions:

• C4d is a versatile biomarker with a significant impact on transplantation outcomes.
• Further research into C4d's role in autoimmunity and pregnancy could lead to improved patient management.
• The evolving understanding of C4d supports its use in personalized medicine, particularly with the advent of complement-blocking drugs.